BiferaRx description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

BiferaRx

Alaven Pharmaceutical LLC

Bifera Rx™ Iron Supplement Tablets


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

Rx Only

BIFERARX DESCRIPTION

BiferaRx™ is a prescription iron supplement. BiferaRx™ is a small oval, film-coated maroon tablet, with black core, debossed and bisected with "AP|85" on one side, and plain on the other.

Each BiferaRx™ tablet contains:

VITAMINS

Amount per serving
Folic Acid 1 mg
B12 (as cyanocobalamin) 25 mcg

MINERALS

Iron
  as PIC (polysaccharide iron complex) 22 mg
  as HIP (heme iron polypeptide as Proferrin® Proferrin® is a registered trademark of Colorado Biolabs, Inc. Cozad, NE.
BiferaRx™ is a trademark of Alaven® Pharmaceutical LLC, Marietta, GA.
- bovine source, USDA certified)
6 mg

INACTIVE INGREDIENTS

Microcrystalline cellulose, croscarmellose sodium, crospovidone, magnesium stearate, silicon dioxide, coating (polyvinyl alcohol, polyethylene glycol, talc, FD&C red no. 40 aluminum lake, titanium dioxide, FD&C blue no. 2 aluminum lake).

BIFERARX INDICATIONS AND USAGE

BiferaRx™ is a prescription iron supplement indicated for use in improving the nutritional status of iron deficiency.

BIFERARX CONTRAINDICATIONS

This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

Hemochromatosis and hemosiderosis are contraindications to iron therapy.

Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6.

Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

PRECAUTIONS

Folic acid when administered as a single agent in doses above 0.1mg daily may obscure pernicious anemia in that hematological remission can occur while neurological manifestations remain progressive. While prescribing this nutritional supplement for pregnant women, nursing mothers, or for women prior to conception, their medical condition and other drugs, herbs, and/or supplements consumption should be considered.

BIFERARX ADVERSE REACTIONS

Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

BIFERARX DOSAGE AND ADMINISTRATION

One tablet daily with or without food or as prescribed by a licensed healthcare provider with prescribing authority.

HOW SUPPLIED

BiferaRx™ tablets are supplied in child-resistant bottles of 90 tablets (NDC 68220-085-90) and as a Professional Sample 5 tablet blister pack (NDC 68220-085-25).

KEEP OUT OF REACH OF CHILDREN.

STORAGE

Store at controlled room temperature 20°-25°C (68°-77°F). Excursions permitted to 15°-30°C (59°-86°F). [See current USP]

Dispense in a tight, light-resistant container to protect from light and moisture.

U.S. Patent No. 7,585,527

For medical inquiries call toll free 1-888-317-0001

www.BiferaRx.com

Manufactured for:
ALAVEN®
PHARMACEUTICAL LLC
Marietta, GA 30062

  • Frykman E, bystron M, Jansoon U, Edberg A, Hansen T. Side effects of iron supplements in blood donors: superior tolerance of heme iron. J Lab Clin Med. 1994; 123:561-564.

6-085-00-01-0310
CL085-00-01-0210

19/03/10      6:20 PM

PRINCIPAL DISPLAY PANEL - 90 Tablet Label

NDC 68220-085-90
90 Tablets

Bifera Rx™
Iron Supplement

Rx Only

Manufactured for:
ALAVEN®
PHARMACEUTICAL LLC
Marietta, GA 30062

www.BiferaRx.com

BiferaRx

BiferaRx

FOLIC ACID, Heme Iron Polypeptide, IRON DEXTRAN, and CYANOCOBALAMIN TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:68220-085
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
FOLIC ACID FOLIC ACID 1 mg
Heme Iron Polypeptide FERRIC CATION 6 mg
IRON DEXTRAN Ferric Cation 22 mg
Cyanocobalamin CYANOCOBALAMIN 25 ug

Inactive Ingredients

Ingredient Name Strength
cellulose, microcrystalline
CROSCARMELLOSE SODIUM
MAGNESIUM STEARATE
CROSPOVIDONE
SILICON DIOXIDE
POLYVINYL ALCOHOL
polyethylene glycol
talc
titanium dioxide
FD&C RED NO. 40
FD&C BLUE NO. 2

Product Characteristics

Color Size Imprint Code Shape
ORANGE 15 mm AP;85 OVAL

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:68220-085-05 5 in 1 BLISTER PACK
2 NDC:68220-085-90 90 in 1 BOTTLE

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
2010-05-01


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.